FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386317966> ?p ?o ?g. }

• W4386317966 abstract "Abstract Background Neoadjuvant chemoradiation followed by surgery is now standard of care for resectable oesophageal cancer. The aim of this study was to analyse various parameters of treatment outcome with respect to pathologic complete responders (pCR) and pathological partial responders. Methods Consecutive 136 patients with operable oesophageal cancer, who received neoadjuvant chemoradiation followed by oesophageal surgery between march 2013 to january 2023 were included. Data was extracted from electronically and physically maintained patient clinical records. Data was collected in mircosoft excel and analysed using Epi Info Version 7.2. Chi square test and student t test were used to test the difference between proportions and means respectively. All tests were 2 tailed and significance level was 0.05. Various demographic, clinical and treatment outcome parameters were analysed according to pathological complete responders (pCR) and pathological partial responders. Results Out of 136 patients, 112(82.3%) had squamous histology. Among 136 patients, 75(55%)had pCR. Postoperative complications were seen in 30(49.18%) of pCR group as compared to 24(32%) in partial responders (p = 0.04). Pulmonary 16(53%) vs 8(33%), cardiac 5(16%) vs 3(12%) and vocal cord palsy 6(20%) vs 8(32%) complications were seen in pCR vs partial responders respectively. 9(14.75%) of pCR group had recurrences as compared to 32(45.33%) in partial responders (p = 0.003). pCR group had distant recurrences in neck 4(66.6%) (p = 0.01) and liver 4(66%) as compared to 2(14.3%) and 4(28.5%) respectively in partial responders. Conclusion High pCR is seen due to more number of patients with squamous histology. pCR has more postoperative pulmonary and cardiac complications which may indicate inherent radiosensitivity and tissue fragility which mandates strict ERAS program and affirms deferred surgery and wait and watch policy for complete clinical responders. Recurrences in pCR are less but are seen mostly in distant sites indicating aggressive surveillance protocol." @default.
• W4386317966 created "2023-09-01" @default.
• W4386317966 creator A5028149900 @default.
• W4386317966 creator A5073305631 @default.
• W4386317966 date "2023-08-30" @default.
• W4386317966 modified "2023-09-27" @default.
• W4386317966 title "291. TREATMENT OUTCOMES ACCORDING TO PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMORADIATION AND SURGEY IN OESOPHAGEAL CANCER" @default.
• W4386317966 doi "https://doi.org/10.1093/dote/doad052.121" @default.
• W4386317966 hasPublicationYear "2023" @default.
• W4386317966 type Work @default.
• W4386317966 citedByCount "0" @default.
• W4386317966 crossrefType "journal-article" @default.
• W4386317966 hasAuthorship W4386317966A5028149900 @default.
• W4386317966 hasAuthorship W4386317966A5073305631 @default.
• W4386317966 hasBestOaLocation W43863179661 @default.
• W4386317966 hasConcept C121608353 @default.
• W4386317966 hasConcept C126322002 @default.
• W4386317966 hasConcept C141071460 @default.
• W4386317966 hasConcept C207886595 @default.
• W4386317966 hasConcept C2778292576 @default.
• W4386317966 hasConcept C2779742542 @default.
• W4386317966 hasConcept C509974204 @default.
• W4386317966 hasConcept C530470458 @default.
• W4386317966 hasConcept C71924100 @default.
• W4386317966 hasConcept C90924648 @default.
• W4386317966 hasConceptScore W4386317966C121608353 @default.
• W4386317966 hasConceptScore W4386317966C126322002 @default.
• W4386317966 hasConceptScore W4386317966C141071460 @default.
• W4386317966 hasConceptScore W4386317966C207886595 @default.
• W4386317966 hasConceptScore W4386317966C2778292576 @default.
• W4386317966 hasConceptScore W4386317966C2779742542 @default.
• W4386317966 hasConceptScore W4386317966C509974204 @default.
• W4386317966 hasConceptScore W4386317966C530470458 @default.
• W4386317966 hasConceptScore W4386317966C71924100 @default.
• W4386317966 hasConceptScore W4386317966C90924648 @default.
• W4386317966 hasIssue "Supplement_2" @default.
• W4386317966 hasLocation W43863179661 @default.
• W4386317966 hasOpenAccess W4386317966 @default.
• W4386317966 hasPrimaryLocation W43863179661 @default.
• W4386317966 hasRelatedWork W2003938723 @default.
• W4386317966 hasRelatedWork W2047967234 @default.
• W4386317966 hasRelatedWork W2084845148 @default.
• W4386317966 hasRelatedWork W2249625608 @default.
• W4386317966 hasRelatedWork W2373547683 @default.
• W4386317966 hasRelatedWork W2381496852 @default.
• W4386317966 hasRelatedWork W2439875401 @default.
• W4386317966 hasRelatedWork W2810304435 @default.
• W4386317966 hasRelatedWork W3006717011 @default.
• W4386317966 hasRelatedWork W4381248208 @default.
• W4386317966 hasVolume "36" @default.
• W4386317966 isParatext "false" @default.
• W4386317966 isRetracted "false" @default.
• W4386317966 workType "article" @default.